Portolano Cavallo

Life Sciences


Medical Devices Regulation: European Commission adopted a proposal to postpone the date of application of the MDR by one year, until 26 May 2021
31 Mar 20
COVID-19 and consumer protection: the impact on selling and advertising practices and early reactions from relevant Italian bodies
How coronavirus impacted sales and advertising from a practical standpoint
27 Mar 20
CJEU Advocate General says that samples of pharmaceutical products cannot be provided to pharmacists
On 30 January 2020, the conclusions of CJEU Advocate General Giovanni Pitruzzella were published on a preliminary ruling from the Bundesgerichtshof, the German Federal Court of Justice, in case C-786/18 (Ratiopharm v Novartis Consumer Health) regarding the free distribution of samples of medicines by the pharmaceutical companies.
23 Mar 20
Cura Italia Decree and Ordinance 630/2020: new rules for public contracts
Law Decree No. 18 of March 17, 2020 (“Cura Italia Decree“) and ordinance No. 630 issued by the Head of the Department of Civil Protection on February 3, 2020 (“Ordinance 630/2020” or “Ordinance”) introduced several derogations to the standard rules that govern the public procurement process for purposes of dealing with the Covid-19 emergency.
23 Mar 20
COVID-19 and IP rights: production of life-saving respiratory valves using 3D printers
The Covid-19 health emergency poses new challenges to legal rule. A hospital’s recent production of respiratory valves using a 3D printer has prompted reflection on intellectual property rights.
German Constitutional Court declared that Act of Approval to the Agreement on a Unified Patent Court is void
Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the life sciences and healthcare industry.
Read more
Our highly-ranked team of professionals will provide news, insights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and venture capital transactions.

October 6, 2023
CBD products: the Administrative Court suspended until October 24 the recent Decree of the Italian Ministry of Health listing cannabidiol for oral use among narcotic drugs, due to the lack o...
October 4, 2023
The Guidelines for regulating contractual relations between universities and research institutes and private sponsors were adopted by the relevant Italian Ministries following the amendment ...
September 21, 2023
CBS products: from September 20th, compositions for oral administration of cannabidiol obtained from Cannabis sativa extracts shall be considered as narcotic drugs in Italy, as they have bee...
July 27, 2023
Payback on medical devices: Italian government announces extension of payment deadline to October 30, 2023
July 21, 2023
On July 21, 2023, the Italian Ministry of Health published new guidelines on health advertising of self-medication drugs (OTC) and non-prescription drugs (SOP), including advertising on new ...
Search by...
Follow us on
Follow us on